» Articles » PMID: 10084106

Allelic Discrimination Using Fluorogenic Probes and the 5' Nuclease Assay

Overview
Journal Genet Anal
Publisher Elsevier
Date 1999 Mar 20
PMID 10084106
Citations 425
Authors
Affiliations
Soon will be listed here.
Abstract

Large-scale screening for known polymorphisms will require techniques with few steps and the ability to automate each of these steps. In this regard, the 5' nuclease, or TaqMan, PCR assay is especially attractive. A fluorogenic probe, consisting of an oligonucleotide labeled with both a fluorescent reporter dye and a quencher dye, is included in a typical PCR. Amplification of the probe-specific product causes cleavage of the probe, generating an increase in reporter fluorescence. By using different reporter dyes, cleavage of allele-specific probes can be detected in a single PCR. The 5' nuclease assay has been successfully used to discriminate alleles that differ by a single base substitution. Guidelines have been developed so that an assay for any single nucleotide polymorphism (SNP) can be quickly designed and implemented. All assays are performed using a single reaction buffer and single thermocycling protocol. Furthermore, a standard method of analysis has been developed that enables automated genotype determination. Applications of this assay have included typing a number of polymorphisms in human drug metabolism genes.

Citing Articles

Uncoupling Proteins Variants Are Linked to Hypercholesterolemia and Abdominal Obesity in Metabolically Unhealthy Women.

Sierra-Ruelas E, Torres-Castillo N, Vizmanos B, Perez W, Martinez-Lopez E Lifestyle Genom. 2025; 18(1):27-35.

PMID: 39820029 PMC: 11838145. DOI: 10.1159/000543484.


Genetic Variants of the Receptor Activator Nuclear of κB Ligand Gene Increase the Risk of Rheumatoid Arthritis in a Mexican Mestizo Population: A Case-Control Study.

Arturo N, Ivan G, Betsabe C, Emilio P, Yussef E, Alejandra R Genes (Basel). 2024; 15(7).

PMID: 39062686 PMC: 11275863. DOI: 10.3390/genes15070907.


Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study.

Gomez-Gaitan E, Garcia-Ortega Y, Saldana-Cruz A, Contreras-Haro B, Gamez-Nava J, Perez-Guerrero E Int J Mol Sci. 2023; 24(19).

PMID: 37834042 PMC: 10572793. DOI: 10.3390/ijms241914594.


Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.

Al-Harbi N, Abdulla M, Vaali-Mohammed M, Bin Traiki T, Alswayyed M, Al-Obeed O Genes (Basel). 2023; 14(4).

PMID: 37107632 PMC: 10138150. DOI: 10.3390/genes14040874.


Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study.

Villagomez Vega A, Gamez Nava J, Ruiz Gonzalez F, Perez Romero M, Trujillo Rangel W, Arana I Genes (Basel). 2023; 14(2).

PMID: 36833451 PMC: 9956997. DOI: 10.3390/genes14020524.